TY - JOUR
T1 - Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review–Based, Individual Participant Data Network Meta-Analysis
AU - REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) Collaborators
AU - Brady, Marian C.
AU - Ali, Myzoon
AU - VandenBerg, Kathryn
AU - Abo, Masahiro
AU - Becker, Frank
AU - Bowen, Audrey
AU - Brandenburg, Caitlin
AU - Breitenstein, Caterina
AU - Copland, David A.
AU - Cranfill, Tamara B.
AU - Pietro-Bachmann, Marie di
AU - Enderby, Pamela
AU - Galli, Federica Lucia
AU - Gandolfi, Marialuisa
AU - Glize, Bertrand
AU - Godecke, Erin
AU - Hawkins, Neil
AU - Hilari, Katerina
AU - Hinckley, Jacqueline
AU - Horton, Simon
AU - Howard, David
AU - Jaecks, Petra
AU - Jesus, Luis M.T.
AU - Kambanaros, Maria
AU - Kang, Eun Kyoung
AU - Khedr, Eman M.
AU - Kong, Anthony Pak-Hin
AU - Kukkonen, Tarja
AU - Laganaro, Marina
AU - Ralph, Matthew A. Lambon
AU - Laska, Ann Charlotte
AU - Leemann, Béatrice
AU - Leff, Alexander P.
AU - Lima, Roxele R.
AU - Lorenz, Antje
AU - MacWhinney, Brian
AU - Marshall, Rebecca Shisler
AU - Mattioli, Flavia
AU - Maviş, İlknur
AU - Meinzer, Marcus
AU - Nilipour, Reza
AU - Noé, Enrique
AU - Paik, Nam-Jong
AU - Palmer, Rebecca
AU - Papathanasiou, Ilias
AU - Patricio, Brigida
AU - Martins, Isabel Pavão
AU - Price, Cathy
AU - Jakovac, Tatjana Prizl
AU - Rochon, Elizabeth
PY - 2021/12/1
Y1 - 2021/12/1
N2 - BACKGROUND AND PURPOSE Optimizing speech and language therapy (SLT) regimens for maximal aphasia recovery is a clinical research priority. We examined associations between SLT intensity (hours/week), dosage (total hours), frequency (days/week), duration (weeks), delivery (face to face, computer supported, individual tailoring, and home practice), content, and language outcomes for people with aphasia. METHODS Databases including MEDLINE and Embase were searched (inception to September 2015). Published, unpublished, and emerging trials including SLT and ≥10 individual participant data on aphasia, language outcomes, and time post-onset were selected. Patient-level data on stroke, language, SLT, and trial risk of bias were independently extracted. Outcome measurement scores were standardized. A statistical inferencing, one-stage, random effects, network meta-analysis approach filtered individual participant data into an optimal model examining SLT regimen for overall language, auditory comprehension, naming, and functional communication pre-post intervention gains, adjusting for a priori-defined covariates (age, sex, time poststroke, and baseline aphasia severity), reporting estimates of mean change scores (95% CI). RESULTS Data from 959 individual participant data (25 trials) were included. Greatest gains in overall language and comprehension were associated with >20 to 50 hours SLT dosage (18.37 [10.58-26.16] Western Aphasia Battery-Aphasia Quotient; 5.23 [1.51-8.95] Aachen Aphasia Test-Token Test). Greatest clinical overall language, functional communication, and comprehension gains were associated with 2 to 4 and 9+ SLT hours/week. Greatest clinical gains were associated with frequent SLT for overall language, functional communication (3-5+ days/week), and comprehension (4-5 days/week). Evidence of comprehension gains was absent for SLT ≤20 hours,
AB - BACKGROUND AND PURPOSE Optimizing speech and language therapy (SLT) regimens for maximal aphasia recovery is a clinical research priority. We examined associations between SLT intensity (hours/week), dosage (total hours), frequency (days/week), duration (weeks), delivery (face to face, computer supported, individual tailoring, and home practice), content, and language outcomes for people with aphasia. METHODS Databases including MEDLINE and Embase were searched (inception to September 2015). Published, unpublished, and emerging trials including SLT and ≥10 individual participant data on aphasia, language outcomes, and time post-onset were selected. Patient-level data on stroke, language, SLT, and trial risk of bias were independently extracted. Outcome measurement scores were standardized. A statistical inferencing, one-stage, random effects, network meta-analysis approach filtered individual participant data into an optimal model examining SLT regimen for overall language, auditory comprehension, naming, and functional communication pre-post intervention gains, adjusting for a priori-defined covariates (age, sex, time poststroke, and baseline aphasia severity), reporting estimates of mean change scores (95% CI). RESULTS Data from 959 individual participant data (25 trials) were included. Greatest gains in overall language and comprehension were associated with >20 to 50 hours SLT dosage (18.37 [10.58-26.16] Western Aphasia Battery-Aphasia Quotient; 5.23 [1.51-8.95] Aachen Aphasia Test-Token Test). Greatest clinical overall language, functional communication, and comprehension gains were associated with 2 to 4 and 9+ SLT hours/week. Greatest clinical gains were associated with frequent SLT for overall language, functional communication (3-5+ days/week), and comprehension (4-5 days/week). Evidence of comprehension gains was absent for SLT ≤20 hours,
U2 - 10.1161/STROKEAHA.121.035216
DO - 10.1161/STROKEAHA.121.035216
M3 - Article
SN - 0039-2499
JO - Stroke
JF - Stroke
ER -